KKR reported Q4 and full-year 2024 with higher-than-expected adjusted EPS of $1.32 but saw a stock drop due to disappointing ...

Q4 2024 Earnings Call Transcript February 4, 2025 KKR & Co. Inc. beats earnings expectations. Reported EPS is $1.32, ...

Barclays analyst Benjamin Budish lowered the firm’s price target on KKR (KKR) to $181 from $185 and keeps an Overweight rating on the shares ...

KKR & Co. (KKR) stock drew retail attention on Tuesday after its fourth-quarter earnings topped Wall Street estimates. The ...

Fundraising momentum accelerated, with $27 billion raised in Q4 compared to $24 billion in Q3. Total 2024 fundraising reached $114 billion, up from $87 billion year-to-date as of Q3. Strategic ...

KKR surpassed earnings expectations, highlighting robust performance in its asset management and insurance segments.

Part of what's helping drive PayPal's modest user growth is marketing, an area in which the company has committed to spending more money. Q4 sales and marketing expense was up more than 34%, and it ...

Beyond analysts' top -and-bottom-line estimates for KKR & Co. (KKR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the ...

AbbVie Q4 adjusted EPS of $2.16 beat estimates, with strong sales of Skyrizi (+57.9%) and Rinvoq (+47.1%) boosting revenue growth. AbbVie raises 2027 revenue forecast for Skyrizi and Rinvoq to $31 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...